Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilofer Azad

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Cancer Cell|April 24, 2026
Anticancer activity of RAS-GTP inhibition in cholangiocarcinomaRodrigo Entrialgo-Cadierno, Konstantina Morali, Iker Feliu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 MutationsJames J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Cancer Cell|April 24, 2026
Anticancer activity of RAS-GTP inhibition in cholangiocarcinomaRodrigo Entrialgo-Cadierno, Konstantina Morali, Iker Feliu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 MutationsJames J Harding, Do-Youn Oh, Teresa Macarulla Mercade, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Mahmoud M Al-Hawary, et al.
Pageof 5